Femasys Net Income

FEMY Stock  USD 0.51  0.02  4.08%   
As of the 17th of February 2026, Femasys shows the Standard Deviation of 6.3, mean deviation of 4.87, and Variance of 39.65. Femasys technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices.

Femasys Total Revenue

1.29 Million

Femasys' financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Femasys' valuation are provided below:
Gross Profit
1.3 M
Market Capitalization
30.2 M
Enterprise Value Revenue
16.8775
Revenue
2.1 M
Earnings Share
(0.69)
We have found one hundred twenty available fundamental signals for Femasys, which can be analyzed and compared to other ratios and to its rivals. All investors should make sure to verify all of Femasys prevailing market performance against the performance between 2010 and 2026 to make sure the company can sustain itself down the road. Enterprise Value is likely to rise to about 26.9 M in 2026, whereas Market Cap is likely to drop slightly above 26.4 M in 2026. This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.
Last ReportedProjected for Next Year
Net Loss-16.9 M-17.8 M
Net Loss-10.3 M-10.8 M
Net Loss-16.9 M-17.8 M
Net Loss(0.97)(1.02)
Net Income Per E B T 0.90  0.80 
Net Loss is likely to drop to about (17.8 M) in 2026. Net Loss is likely to drop to about (10.8 M) in 2026.
  
Build AI portfolio with Femasys Stock
The evolution of Net Income for Femasys provides essential context for understanding the company's financial health trajectory. By analyzing this metric's behavior over time, investors can assess whether recent trends align with long-term patterns, and how Femasys compares to historical norms and industry peers.

Latest Femasys' Net Income Growth Pattern

Below is the plot of the Net Income of Femasys over the last few years. Net income is one of the most important fundamental items in finance. It plays a large role in Femasys financial statement analysis. It represents the amount of money remaining after all of Femasys operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. It is Femasys' Net Loss historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Femasys' overall financial position and show how it may be relating to other accounts over time.
ViewLast Reported (18.82 M)10 Years Trend
Slightly volatile
   Net Income   
       Timeline  

Femasys Net Income Regression Statistics

Arithmetic Mean(12,138,054)
Coefficient Of Variation(26.09)
Mean Deviation2,262,143
Median(11,271,948)
Standard Deviation3,166,325
Sample Variance10T
Range11.9M
R-Value(0.52)
Mean Square Error7.8T
R-Squared0.27
Significance0.03
Slope(324,598)
Total Sum of Squares160.4T

Femasys Net Income History

2026-17.8 M
2025-16.9 M
2024-18.8 M
2023-14.2 M
2022-11.4 M
2021-7.5 M
2020-6.9 M

Other Fundumenentals of Femasys

Femasys Net Income component correlations

Femasys Net Income Driver Correlations

Understanding the fundamental principles of building solid financial models for Femasys is extremely important. It helps to project a fair market value of Femasys Stock properly, considering its historical fundamentals such as Net Income. Since Femasys' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Femasys' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Femasys' interrelated accounts and indicators.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Femasys. Market participants price Femasys higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Femasys assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share
(0.69)
Revenue Per Share
0.07
Quarterly Revenue Growth
0.314
Return On Assets
(0.69)
Return On Equity
(3.76)
Femasys's market price often diverges from its book value, the accounting figure shown on Femasys's balance sheet. Smart investors calculate Femasys' intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Femasys' trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Femasys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Femasys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Femasys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Femasys 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Femasys' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Femasys.
0.00
11/19/2025
No Change 0.00  0.0 
In 2 months and 31 days
02/17/2026
0.00
If you would invest  0.00  in Femasys on November 19, 2025 and sell it all today you would earn a total of 0.00 from holding Femasys or generate 0.0% return on investment in Femasys over 90 days. Femasys is related to or competes with Harvard Bioscience, Envoy Medical, Ainos, Curis, Dare Bioscience, Ekso Bionics, and Vivos Therapeutics. Femasys Inc., a biomedical company, focuses on womens healthcare market in the United States More

Femasys Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Femasys' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Femasys upside and downside potential and time the market with a certain degree of confidence.

Femasys Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Femasys' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Femasys' standard deviation. In reality, there are many statistical measures that can use Femasys historical prices to predict the future Femasys' volatility.
Hype
Prediction
LowEstimatedHigh
0.030.526.31
Details
Intrinsic
Valuation
LowRealHigh
0.081.677.46
Details
4 Analysts
Consensus
LowTargetHigh
4.705.175.74
Details
Earnings
Estimates (0)
LowProjected EPSHigh
-0.14-0.14-0.14
Details

Femasys February 17, 2026 Technical Indicators

Femasys Backtested Returns

Femasys secures Sharpe Ratio (or Efficiency) of -0.085, which denotes the company had a -0.085 % return per unit of risk over the last 3 months. Femasys exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Femasys' Variance of 39.65, standard deviation of 6.3, and Mean Deviation of 4.87 to check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.87, which means a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Femasys will likely underperform. At this point, Femasys has a negative expected return of -0.5%. Please make sure to confirm Femasys' jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Femasys performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.65  

Good predictability

Femasys has good predictability. Overlapping area represents the amount of predictability between Femasys time series from 19th of November 2025 to 3rd of January 2026 and 3rd of January 2026 to 17th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Femasys price movement. The serial correlation of 0.65 indicates that roughly 65.0% of current Femasys price fluctuation can be explain by its past prices.
Correlation Coefficient0.65
Spearman Rank Test0.38
Residual Average0.0
Price Variance0.0
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
Competition

Femasys Accumulated Other Comprehensive Income

Accumulated Other Comprehensive Income

1.21 Million

At this time, Femasys' Accumulated Other Comprehensive Income is fairly stable compared to the past year.
Based on the recorded statements, Femasys reported net income of (18.82 Million). This is 105.51% lower than that of the Health Care Equipment & Supplies sector and 118.89% lower than that of the Health Care industry. The net income for all United States stocks is 103.3% higher than that of the company.

Femasys Net Income Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Femasys' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Femasys could also be used in its relative valuation, which is a method of valuing Femasys by comparing valuation metrics of similar companies.
Femasys is currently under evaluation in net income category among its peers.

Femasys Institutional Holders

Institutional Holdings refers to the ownership stake in Femasys that is held by large financial organizations, pension funds or endowments. Institutions may hold large blocks of Femasys' outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Femasys' value.
Shares
Northern Trust Corp2025-06-30
53.5 K
Hrt Financial Llc2025-06-30
48.6 K
Advisor Group Holdings, Inc.2025-06-30
47.1 K
Nwf Advisory Services Inc2025-03-31
47.1 K
Global Retirement Partners, Llc.2025-06-30
33 K
Tri Locum Partners Lp2025-06-30
30.6 K
Sontag Advisory Llc2025-06-30
28.1 K
Ocean Capital Management, Llc2025-06-30
24.3 K
Northwestern Mutual Wealth Management Co2025-06-30
20 K
Dauntless Investment Group, Llc2025-06-30
2.3 M
Vanguard Group Inc2025-06-30
951.9 K

Femasys Fundamentals

About Femasys Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Femasys's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Femasys using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Femasys based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Femasys Stock Analysis

When running Femasys' price analysis, check to measure Femasys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Femasys is operating at the current time. Most of Femasys' value examination focuses on studying past and present price action to predict the probability of Femasys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Femasys' price. Additionally, you may evaluate how the addition of Femasys to your portfolios can decrease your overall portfolio volatility.